The Significance of HASBLED and CHADS2 and CHADS2VASC2

C: CHF
H: HT
A2: Age 75+
D: DM
S2: Stroke/TIA/PE/DVT
V: Vascular issues
A: Age 65-74
S: Sex  Female

Interpretation:
Stroke Risk per year for the pt
0-0%
1-1.3%
2-2.2%
3-3.2%
4-4.0%
5-6.7%
6-9.8%
7-9.6%
8-6.7%
9-15.2%

Application to Afib: 2+ gets anticoagulation tx. 1, either way. 0 gets rate control. Tx: Oral anticoagulant, with well controlled Vitamin K Antagonist (VKA, e.g. warfarin with time in therapeutic range >70%), or a Non-VKA Oral Anticoagulant (NOAC, e.g. dabigatran, rivaroxaban, edoxaban or apixaban)


H: HT >160 sys
A: Abn Liver, Kidney Fxn (1 ea)
S: Stroke Hx
B: Bleed Hx
L: Labile INRs
E: Elderly >65yo
D: Drugs, EtOH (1 ea)

Interpretation:
Absolute Serious Bleed Risk
0-1.13%
1-1.02%
2-1.88%
3-3.74%
4-8.7%
5-12.5%